Search

Subject 613.9

1. Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study. (1st November 2016)

Authors:
Kalams, Spyros A.; Rogers, Lisa M.; Smith, Rita M.; Barnett, Louise; Crumbo, Katie; Sumner, Shonda; Prashad, Naomi; Rybczyk, Kyle; Milne, Ginger; Dowd, Scot E.; Chong, Erica; Winikoff, Beverly; Aronoff, David M.
Journal:
European journal of contraception & reproductive health care
Issue:
Volume 21:Number 6(2016:Dec.)
Page Start:
436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Chlamydia screening and prophylactic treatment in termination of pregnancy clinics in the Netherlands and Great Britain: a qualitative study. (1st November 2016)

Authors:
van den Berg, Georgina F.; Picavet, Charles; Hoopman, Rianne; Lohr, Patricia A.; Op de Coul, Eline L. M.
Journal:
European journal of contraception & reproductive health care
Issue:
Volume 21:Number 6(2016:Dec.)
Page Start:
467
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Contraceptive behaviour of Christian and Muslim teenagers at the time of abortion and post-abortion in Thrace, Greece. (1st November 2016)

Authors:
Tsikouras, Panagiotis; Koukouli, Zacharoula; Psarros, Nikolaos; Manav, Bachar; Tsagias, Nikolaos; Galazios, Georgios
Journal:
European journal of contraception & reproductive health care
Issue:
Volume 21:Number 6(2016:Dec.)
Page Start:
462
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗